"Heyuan Liji" is a joint venture between Heyuan Biotechnology (stock code: 688238) and Liji Biotechnology, specializing in the "Liji Biotechnology" and "Life-ilab" reagent brands
Feedback Form-5-8F for Cryovial Solution (Guangxi Medical University Cancer Hospital)